NTRA (Natera, Inc. Common Stock) Stock Analysis - Politician Trades
Natera, Inc. Common Stock (NTRA) is a publicly traded Healthcare sector company. As of May 21, 2026, NTRA trades at $205.04 with a market cap of $27.57B and a P/E ratio of -124.56. NTRA moved +4.51% today. Year to date, NTRA is -13.69%; over the trailing twelve months it is +32.61%. Its 52-week range spans $117.27 to $256.36. Analyst consensus is strong buy with an average price target of $262.14. Rallies surfaces NTRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded NTRA stock?
Recent politician trading activity in NTRA includes disclosures from Josh Gottheimer, Josh Gottheimer, Josh Gottheimer, and Bill Hagerty. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
NTRA Key Metrics
Key financial metrics for NTRA
Metric
Value
Price
$205.04
Market Cap
$27.57B
P/E Ratio
-124.56
EPS
$-1.62
Dividend Yield
0.00%
52-Week High
$256.36
52-Week Low
$117.27
Volume
1.33M
Avg Volume
0
Revenue (TTM)
$2.50B
Net Income
$-226.31M
Gross Margin
0.00%
Congressional Trades in NTRA
Josh Gottheimer purchase NTRA on Sep 22, 2025 (amount: $15.00K) for Joint.
Josh Gottheimer purchase NTRA on Aug 22, 2025 (amount: $15.00K) for Joint.
Josh Gottheimer sale NTRA on Jul 22, 2025 (amount: $15.00K) for Joint.
Bill Hagerty sale (partial) NTRA on Apr 20, 2021 (amount: $15.00K) for Self.
Recent politician trading activity in NTRA includes disclosures from Josh Gottheimer, Josh Gottheimer, Josh Gottheimer, and Bill Hagerty. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in NTRA?
Yes. Rallies tracks politician and congressional stock disclosures for NTRA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is NTRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NTRA. It does not provide personalized investment advice.